MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Neuropathological findings in a SPG4 gene mutation carrier

    S. Forcén, I. Aldecoa, AM. Crespo, O. Ramos, L. Ispierto, R. álvarez, D. Vilas (Badalona, Spain)

    Objective: To describe the clinical and neuropathological findings of a patient carrier of a mutation in the SPG4 gene. Background: Hereditary spastic paraplegia (HSP) linked…
  • 2019 International Congress

    Investigating Physical and Cognitive Changes over Two Years in Patients with Moderate to Late Stage Parkinson’s Disease in Northumbria

    L. Macdonald, I. Sayers, S. Dempsey, W. Gray, A. Hand, R. Walker (North Shields, United Kingdom)

    Objective: Investigate changes in timed up and go (TUG), grip strength, MoCA and MMSE scores and explore which areas of cognition are most commonly affected.…
  • 2019 International Congress

    Validation of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease

    J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To assess the psychometric properties of the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s disease (PD) across levels of cognitive abilities.…
  • 2019 International Congress

    Social cognition in Parkinson’s disease

    L. Alonso-Recio, C. Merino, P. Martín, JM. Serrrano (Collado Villalba (madrid), Spain)

    Objective: The aim of the present study was to assess social cognition skills in non-demented Parkinson’s disease (PD) patients. Background: Social cognition is a multidimensional…
  • 2019 International Congress

    Resting-state EEG spectral power in Parkinson’s disease

    J. Dalrymple-Alford, R. Shoorangiz, E. Petersen, R. Jones, B. Elias, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson (Christchurch, New Zealand)

    Objective: To examine the relationship between spectral power of resting state EEG (rsEEG) and cognition in Parkinson’s disease (PD). Background: Alzheimer patients have reduced rsEEG…
  • 2019 International Congress

    Correlation between striatal CIT uptake and Mini-Mental State Examination in Parkinson’s disease

    OD. Kwon, SG. Park, SB. Lee, JA. Park (Daegu, Republic of Korea)

    Objective: This study was performed to identify any relationship between the amount of decline of receptor uptake of CIT and Mini-Mental State Examination(MMSE) score in…
  • 2019 International Congress

    DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead

    C. Nombela, A. Lozano, C. Villanueva-Iza, J. Barcia (Madrid, Spain)

    Objective: The study proposed a new Deep Brain Stimulation (DBS) approach in Parkinson´s disease (PD): the Globus pallidus pars interna (GPi) + Nucleus Basalis of…
  • 2019 International Congress

    Neurocognitive changes after STN-DBS among PD patients – a 2-year follow-up study in Hong Kong

    V. Tang, D. Chan, XL. Zhu, D. Chan, C. Lau, A. Chan, K. Ma, J. Yeung, V. Mok, W. Poon (N.t., Hong Kong)

    Objective: The study aimed to examine the neurocognitive changes following STN-DBS in patients with PD. Background: Neurocognitive evaluation is a standard procedure preoperatively in patients…
  • 2019 International Congress

    Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

    M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

    Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…
  • 2019 International Congress

    Increased hub function in posterior medial cortex in Parkinson’s disease without mild cognitive impairement – A resting state fMRI study –

    A. Nagano-Saito, P. Bellec, S. Jobert, B. Mejia-Constain, C. Degroot, A. Lafontaine, A. Hanganu, J. Lissemore, K. Smart, C. Benkelfat, O. Monchi (Montreal, QC, Canada)

    Objective: Using resting-state functional MRI (rsfMRI) data of younger and older healthy volunteers and patients with Parkinson’s disease (PD) with and without mild cognitive impairment…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley